gpollara.bsky.social profile picture

Gabriele Pollara

@gpollara.bsky.social

9266 Followers

1533 Following

Infectious Diseases doctor (at UCLH) and academic (at UCL). Research focuses on immune responses to TB and leprosy, but I'm also involved in too many other projects I probably shouldn't be...

  1. 'The prominence of soluble receptors such as IL-2RA & TNFRSF1B in the severity-associated signature suggests a dynamic regulation of immune signaling during acute infection. This (...) highlights the importance of receptor shedding as a potential biomarker of immune activation' #Immunology #Malaria

    While the immune response to Plasmodium falciparum malaria has been studied extensively,
the circulating proteome and its cellular origins remain poorly characterized. Lautenbach
et al. address this b...

    Systems analysis of clinical malaria reveals proteomic perturbation and innate-adaptive crosstalk linked to disease severity

    While the immune response to Plasmodium falciparum malaria has been studied extensively, the circulating proteome and its cellular origins remain poorly characterized. Lautenbach et al. address this b...

    1
  2. Bye, data centre. Hello, cloud. Crossref's main systems are now in the cloud—processing jobs in seconds instead of hours, cutting long queues, and improving disaster recovery. Read about the move, the challenges, and what's next: https://doi.org/10.64000/wd6rx-vpq73 #OpenInfrastucture #DataCentre

    Screenshot of Crossref blog post announcing migration of main systems to the cloud, with link to crossref.org/blog.
    0
  3. Generative AI framework invents 2 new potential antibiotics that could kill drug-resistant gonorrhoea & MRSA. 🧪💊🦠

    "While AI promises to dramatically improve drug discovery & development, we still need to do the hard yards when it comes to testing safety and efficacy." www.bbc.co.uk/news/article...

    Two new potential drugs have been designed by AI to kill drug-resistant bacteria, in a major Massachusetts Institute of Technology study.

    AI designs new superbug-killing antibiotics for gonorrhoea and MRSA

    Two new potential drugs have been designed by AI to kill drug-resistant bacteria, in a major Massachusetts Institute of Technology study.

    2
  4. Link to new study in Cell (sadly not open access 😞):

    A generative deep learning approach to de novo antibiotic design 🧪💊🦠 www.cell.com/cell/abstrac...

    A generative AI platform is developed for de novo antibiotic design, yielding lead
compounds with selective antibacterial activity, distinct mechanisms of action, and
in vivo efficacy against multidru...

    A generative deep learning approach to de novo antibiotic design

    A generative AI platform is developed for de novo antibiotic design, yielding lead compounds with selective antibacterial activity, distinct mechanisms of action, and in vivo efficacy against multidru...

    0